Ronald Levy, MD

Medical oncologist, Lymphoma specialist

Robert K. and Helen K. Summy Professor in the School of Medicine

Lymphoma Program

  • 875 Blake Wilbur Drive
  • Palo Alto, CA 94304
  • Phone: 650-498-6000
Learn More About the Clinic Getting Here Make An Appointment

Professional Education

Board Certification: Medical Oncology, American Board of Internal Medicine (1979)

Fellowship: Stanford University School of Medicine (1973) CA

Residency: Massachusetts General Hospital (1970) MA

Internship: Massachusetts General Hospital (1969) MA

Board Certification: Internal Medicine, American Board of Internal Medicine (1973)

Medical Education: Stanford University School of Medicine (1968) CA

AB, Harvard University, Biochemistry (1963)

MD, Stanford Univerisity, Medicine (1968)

Honors & Awards

King Faisal International Prize, King Faisal Foundation (2009)

Member, National Academy of Sciences (2008)

di Villiers International Achievement Award, Leukemia and Lymphoma Society (2007)

Member, Institute of Medicine (2007)

Damashek Prize, American Society of Hematology (2004)

Jeffrey A. Gottlieb Memorial Award, M.D. Anderson Cancer Center (2003)

Medal of Honor, American Cancer Society (2000)

C.Chester Stock Award, Memorial Sloan-Kettering Cancer Center (2000)

Charles Kettering Prize, General Motors Cancer Research Foundation (1999)

Karnofsky Award, American Society of Clinical Oncology (1999)

Clinical Trials

Clinical trials are research studies that evaluate a new medical approach, device, drug, or other treatment. As a Stanford Health Care patient, you may have access to the latest, advanced clinical trials.

Open trials refer to studies currently accepting participants. Closed trials are not currently enrolling, but may open in the future.

Intratumoral Anti-CTLA-4 Therapy: Enhancing Efficacy While Avoiding Toxicity
Marabelle, A., Kohrt, H., & Levy, R. (2013). Intratumoral Anti-CTLA-4 Therapy: Enhancing Efficacy While Avoiding Toxicity. CLINICAL CANCER RESEARCH, 19(19), 5261-5263.

Improvements in observed and relative survival in follicular grade 1-2 lymphoma during 4 decades: the Stanford University experience
Tan, D., Horning, S. J., Hoppe, R. T., Levy, R., Rosenberg, S. A., & Advani, R. H. (2013). Improvements in observed and relative survival in follicular grade 1-2 lymphoma during 4 decades: the Stanford University experience. BLOOD, 122(6), 981-987.

Hierarchy in somatic mutations arising during genomic evolution and progression of follicular lymphoma
Green, M. R., Gentles, A. J., Nair, R. V., Irish, J. M., Kihira, S., & Alizadeh, A. A. (2013). Hierarchy in somatic mutations arising during genomic evolution and progression of follicular lymphoma. BLOOD, 121(9), 1604-1611.

High PD-1 expression and suppressed cytokine signaling distinguish T cells infiltrating follicular lymphoma tumors from peripheral T cells
Myklebust, J. H., Irish, J. M., Brody, J., Czerwinski, D. K., Houot, R., & Levy, R. (2013). High PD-1 expression and suppressed cytokine signaling distinguish T cells infiltrating follicular lymphoma tumors from peripheral T cells. BLOOD, 121(8), 1367-1376.

Self-antigen recognition by follicular lymphoma B-cell receptors
Sachen, K. L., Strohman, M. J., Singletary, J., Alizadeh, A. A., Kattah, N. H., & Levy, R. (2012). Self-antigen recognition by follicular lymphoma B-cell receptors. BLOOD, 120(20), 4182-4190.

A vaccine directed to B cells and produced by cell-free protein synthesis generates potent antilymphoma immunity
Ng, P. P., Jia, M., Patel, K. G., Brody, J. D., Swartz, J. R., & Levy, R. (2012). A vaccine directed to B cells and produced by cell-free protein synthesis generates potent antilymphoma immunity. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 109(36), 14526-14531.

CD137 Is Expressed in Follicular Dendritic Cell Tumors and in Classical Hodgkin and T-Cell Lymphomas Diagnostic and Therapeutic Implications
Anderson, M. W., Zhao, S., Freud, A. G., Czerwinski, D. K., Kohrt, H., & Natkunam, Y. (2012). CD137 Is Expressed in Follicular Dendritic Cell Tumors and in Classical Hodgkin and T-Cell Lymphomas Diagnostic and Therapeutic Implications. AMERICAN JOURNAL OF PATHOLOGY, 181(3), 795-803.

Boosting antibody-dependant cellular cytotoxicity against tumor cells with a CD137 stimulatory antibody
Houot, R., Kohrt, H., & Levy, R. (2012). Boosting antibody-dependant cellular cytotoxicity against tumor cells with a CD137 stimulatory antibody. ONCOIMMUNOLOGY, 1(6), 957-958.

Combination strategies to enhance antitumor ADCC
Kohrt, H. E., Houot, R., Marabelle, A., Cho, H. J., Osman, K., & Brody, J. (2012). Combination strategies to enhance antitumor ADCC. IMMUNOTHERAPY, 4(5), 511-527.

Adoptive Cell Therapy for Lymphoma with CD4 T Cells Depleted of CD137-Expressing Regulatory T Cells
Goldstein, M. J., Kohrt, H. E., Houot, R., Varghese, B., Lin, J. T., & Levy, R. (2012). Adoptive Cell Therapy for Lymphoma with CD4 T Cells Depleted of CD137-Expressing Regulatory T Cells. CANCER RESEARCH, 72(5), 1239-1247.

Complementary costimulation of human T-cell subpopulations by cluster of differentiation 28 (CD28) and CD81
Sagi, Y., Landrigan, A., Levy, R., & Levy, S. (2012). Complementary costimulation of human T-cell subpopulations by cluster of differentiation 28 (CD28) and CD81. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 109(5), 1613-1618.

Targeting immune effector cells to promote antibody-induced cytotoxicity in cancer immunotherapy
Houot, R., Kohrt, H. E., Marabelle, A., & Levy, R. (2011). Targeting immune effector cells to promote antibody-induced cytotoxicity in cancer immunotherapy. TRENDS IN IMMUNOLOGY, 32(11), 510-516.

Prediction of survival in diffuse large B-cell lymphoma based on the expression of 2 genes reflecting tumor and microenvironment
Alizadeh, A. A., Gentles, A. J., Alencar, A. J., Liu, C. L., Kohrt, H. E., & Levy, R. (2011). Prediction of survival in diffuse large B-cell lymphoma based on the expression of 2 genes reflecting tumor and microenvironment. BLOOD, 118(5), 1350-1358.

Prolonged disease-free survival and overall survival with CVP alternating with fludarabine in advanced follicular lymphoma
Ai, W. Z., Kohrt, H. Ek., Timmerman, J., Hwang, J., Hsu, F. J., & Levy, R. (2011). Prolonged disease-free survival and overall survival with CVP alternating with fludarabine in advanced follicular lymphoma. AMERICAN JOURNAL OF HEMATOLOGY, 86(6), 515-518.

Active and Passive Immunotherapy for Lymphoma: Proving Principles and Improving Results
Brody, J., Kohrt, H., Marabelle, A., & Levy, R. (2011). Active and Passive Immunotherapy for Lymphoma: Proving Principles and Improving Results. JOURNAL OF CLINICAL ONCOLOGY, 29(14), 1864-1875.

The Efficacy of HGAL and LMO2 in the Separation of Lymphomas Derived From Small B Cells in Nodal and Extranodal Sites, Including the Bone Marrow
Younes, S. F., Beck, A. H., Ohgami, R. S., Lossos, I. S., Levy, R., & Natkunam, Y. (2011). The Efficacy of HGAL and LMO2 in the Separation of Lymphomas Derived From Small B Cells in Nodal and Extranodal Sites, Including the Bone Marrow. AMERICAN JOURNAL OF CLINICAL PATHOLOGY, 135(5), 697-708.

Immunomodulating antibodies and drugs for the treatment of hematological malignancies
Houot, R., Kohrt, H., Goldstein, M. J., & Levy, R. (2011). Immunomodulating antibodies and drugs for the treatment of hematological malignancies. CANCER AND METASTASIS REVIEWS, 30(1), 97-109.

CD137 stimulation enhances the antilymphoma activity of anti-CD20 antibodies
Kohrt, H. E., Houot, R., Goldstein, M. J., Weiskopf, K., Alizadeh, A. A., & Levy, R. (2011). CD137 stimulation enhances the antilymphoma activity of anti-CD20 antibodies. BLOOD, 117(8), 2423-2432.

A CpG-loaded tumor cell vaccine induces antitumor CD4(+) T cells that are effective in adoptive therapy for large and established tumors
Goldstein, M. J., Varghese, B., Brody, J. D., Rajapaksa, R., Kohrt, H., & Levy, R. (2011). A CpG-loaded tumor cell vaccine induces antitumor CD4(+) T cells that are effective in adoptive therapy for large and established tumors. BLOOD, 117(1), 118-127.

Escherichia coli-based production of a tumor idiotype antibody fragment - tetanus toxin fragment C fusion protein vaccine for B cell lymphoma
Patel, K. G., Ng, P. P., Levy, S., Levy, R., & Swartz, J. R. (2011). Escherichia coli-based production of a tumor idiotype antibody fragment - tetanus toxin fragment C fusion protein vaccine for B cell lymphoma. PROTEIN EXPRESSION AND PURIFICATION, 75(1), 15-20.

In Situ Vaccination With a TLR9 Agonist Induces Systemic Lymphoma Regression: A Phase I/II Study
Brody, J. D., Ai, W. Z., Czerwinski, D. K., Torchia, J. A., Levy, M., & Levy, R. (2010). In Situ Vaccination With a TLR9 Agonist Induces Systemic Lymphoma Regression: A Phase I/II Study. JOURNAL OF CLINICAL ONCOLOGY, 28(28), 4324-4332.

Anti-CD47 Antibody Synergizes with Rituximab to Promote Phagocytosis and Eradicate Non-Hodgkin Lymphoma
Chao, M. P., Alizadeh, A. A., Tang, C., Myklebust, J. H., Varghese, B., & Majeti, R. (2010). Anti-CD47 Antibody Synergizes with Rituximab to Promote Phagocytosis and Eradicate Non-Hodgkin Lymphoma. CELL, 142(5), 699-713.

Immunoarchitectural Patterns in Follicular Lymphoma: Efficacy of HGAL and LMO2 in the Detection of the Interfollicular and Diffuse Components
Younes, S. F., Beck, A. H., Lossos, I. S., Levy, R., Warnke, R. A., & Natkunam, Y. (2010). Immunoarchitectural Patterns in Follicular Lymphoma: Efficacy of HGAL and LMO2 in the Detection of the Interfollicular and Diffuse Components. AMERICAN JOURNAL OF SURGICAL PATHOLOGY, 34(9), 1266-1276.

B-cell signaling networks reveal a negative prognostic human lymphoma cell subset that emerges during tumor progression
Irish, J. M., Myklebust, J. H., Alizadeh, A. A., Houot, R., Sharman, J. P., & Levy, R. (2010). B-cell signaling networks reveal a negative prognostic human lymphoma cell subset that emerges during tumor progression. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 107(29), 12747-12754.

C-C Chemokine Receptor 1 Expression in Human Hematolymphoid Neoplasia
Anderson, M. W., Zhao, S., Ai, W. Z., Tibshirani, R., Levy, R., & Natkunam, Y. (2010). C-C Chemokine Receptor 1 Expression in Human Hematolymphoid Neoplasia. AMERICAN JOURNAL OF CLINICAL PATHOLOGY, 133(3), 473-483.

CD81 protein is expressed at high levels in normal germinal center B cells and in subtypes of human lymphomas
Luo, R. F., Zhao, S., Tibshirani, R., Myklebust, J. H., Sanyal, M., & Natkunam, Y. (2010). CD81 protein is expressed at high levels in normal germinal center B cells and in subtypes of human lymphomas. HUMAN PATHOLOGY, 41(2), 271-280.

Cell-free production of Gaussia princeps luciferase - antibody fragment bioconjugates for ex vivo detection of tumor cells
Patel, K. G., Ng, P. P., Kuo, C.-C., Levy, S., Levy, R., & Swartz, J. R. (2009). Cell-free production of Gaussia princeps luciferase - antibody fragment bioconjugates for ex vivo detection of tumor cells. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 390(3), 971-976.

Generation of CD8(+) T cell-mediated immunity against idiotype-negative lymphoma escapees
Varghese, B., Widman, A., Do, J., Taidi, B., Czerwinski, D. K., & Levy, R. (2009). Generation of CD8(+) T cell-mediated immunity against idiotype-negative lymphoma escapees. BLOOD, 114(20), 4477-4485.

Therapeutic effect of CD137 immunomodulation in lymphoma and its enhancement by T-reg depletion
Houot, R., Goldstein, M. J., Kohrt, H. E., Myklebust, J. H., Alizadeh, A. A., & Levy, R. (2009). Therapeutic effect of CD137 immunomodulation in lymphoma and its enhancement by T-reg depletion. BLOOD, 114(16), 3431-3438.

Lymphoma immunotherapy: vaccines, adoptive cell transfer and immunotransplant
Brody, J., & Levy, R. (2009). Lymphoma immunotherapy: vaccines, adoptive cell transfer and immunotransplant. IMMUNOTHERAPY, 1(5), 809-824.

Molecular Outcome Prediction in Diffuse Large-B-Cell Lymphoma
Alizadeh, A. A., Gentles, A. J., Lossos, I. S., & Levy, R. (2009). Molecular Outcome Prediction in Diffuse Large-B-Cell Lymphoma. NEW ENGLAND JOURNAL OF MEDICINE, 360(26), 2794-2795.

Anti-idiotype antibody response after vaccination correlates with better overall survival in follicular lymphoma
Ai, W. Z., Tibshirani, R., Taidi, B., Czerwinski, D., & Levy, R. (2009). Anti-idiotype antibody response after vaccination correlates with better overall survival in follicular lymphoma. BLOOD, 113(23), 5743-5746.

Vaccines for lymphomas: Idiotype vaccines and beyond
Houot, R., & Levy, R. (2009). Vaccines for lymphomas: Idiotype vaccines and beyond. BLOOD REVIEWS, 23(3), 137-142.

T-cell modulation combined with intratumoral CpG cures lymphoma in a mouse model without the need for chemotherapy
Houot, R., & Levy, R. (2009). T-cell modulation combined with intratumoral CpG cures lymphoma in a mouse model without the need for chemotherapy. BLOOD, 113(15), 3546-3552.

The Transcription Factor LMO2 Is a Robust Marker of Vascular Endothelium and Vascular Neoplasms and Selected Other Entities
Gratzinger, D., Zhao, S., West, R., Rouse, R. V., Vogel, H., & Natkunam, Y. (2009). The Transcription Factor LMO2 Is a Robust Marker of Vascular Endothelium and Vascular Neoplasms and Selected Other Entities. AMERICAN JOURNAL OF CLINICAL PATHOLOGY, 131(2), 264-278.

Immunotransplantation preferentially expands T-effector cells over T-regulatory cells and cures large lymphoma tumors
Brody, J. D., Goldstein, M. J., Czerwinski, D. K., & Levy, R. (2009). Immunotransplantation preferentially expands T-effector cells over T-regulatory cells and cures large lymphoma tumors. BLOOD, 113(1), 85-94.

Idiotype vaccination for lymphoma: moving towards optimisation
Houot, R., & Levy, R. (2009). Idiotype vaccination for lymphoma: moving towards optimisation. LEUKEMIA & LYMPHOMA, 50(1), 1-2.

Genetic polymorphism of the inhibitory IgG Fc receptor FcRIIb is not associated with clinical outcome in patients with follicular lymphoma treated with rituximab
Weng, W.-K., & Levy, R. (2009). Genetic polymorphism of the inhibitory IgG Fc receptor FcRIIb is not associated with clinical outcome in patients with follicular lymphoma treated with rituximab. LEUKEMIA & LYMPHOMA, 50(5), 723-727.

Follicular lymphoma B cells induce the conversion of conventional CD4(+) T cells to T-regulatory cells
Ai, W. Z., Hou, L.-Z., Zeiser, R., Czerwinski, D., Negrin, R. S., & Levy, R. (2009). Follicular lymphoma B cells induce the conversion of conventional CD4(+) T cells to T-regulatory cells. INTERNATIONAL JOURNAL OF CANCER, 124(1), 239-244.

Immunoglobulin G Fc receptor polymorphisms do not correlate with response to chemotherapy or clinical course in patients with follicular lymphoma
Weng, W.-K., & Levy, R. (2009). Immunoglobulin G Fc receptor polymorphisms do not correlate with response to chemotherapy or clinical course in patients with follicular lymphoma. LEUKEMIA & LYMPHOMA, 50(9), 1494-1500.

Tumor-specific recombinant idiotype immunisation after chemotherapy as initial treatment for follicular non-Hodgkin lymphoma
Timmerman, J. M., Vose, J. M., Czerwinski, D. K., Weng, W.-K., Ingolia, D., & Levy, R. (2009). Tumor-specific recombinant idiotype immunisation after chemotherapy as initial treatment for follicular non-Hodgkin lymphoma. LEUKEMIA & LYMPHOMA, 50(1), 37-46.

Neither CD68+Nor CD163+Macrophages Are Associated with Decreased Survival in Follicular Lymphoma
Gratzinger, D., Ai, W., Tibshirani, R., Levy, R., & Natkunam, Y. (2008). Neither CD68+Nor CD163+Macrophages Are Associated with Decreased Survival in Follicular Lymphoma. BLOOD, 112(11), 1284-1284.

Paraffin-based 6-gene model predicts outcome in diffuse large B-cell lymphoma patients treated with R-CHOP
Malumbres, R., Chen, J., Tibshirani, R., Johnson, N. A., Sehn, L. H., & Lossos, I. S. (2008). Paraffin-based 6-gene model predicts outcome in diffuse large B-cell lymphoma patients treated with R-CHOP. BLOOD, 111(12), 5509-5514.

LMO2 protein expression predicts survival in patients with diffuse large B-Cell lymphoma treated with anthracycline-based chemotherapy with and without rituximab
Natkunam, Y., Farinha, P., Hsi, E. D., Hans, C. P., Tibshirani, R., & Lossos, I. S. (2008). LMO2 protein expression predicts survival in patients with diffuse large B-Cell lymphoma treated with anthracycline-based chemotherapy with and without rituximab. JOURNAL OF CLINICAL ONCOLOGY, 26(3), 447-454.

"Minor" BCL2 breakpoints in follicular lymphoma - Frequency and correlation with grade and disease presentation in 236 cases
Weinberg, O. K., Ai, W. Z., Mariappan, M. R., Shum, C., Levy, R., & Arber, D. A. (2007). "Minor" BCL2 breakpoints in follicular lymphoma - Frequency and correlation with grade and disease presentation in 236 cases. JOURNAL OF MOLECULAR DIAGNOSTICS, 9(4), 530-537.

Lymphoma immunotherapy with CpG oligodeoxynucleotides requires TLR9 either in the host or in the tumor itself
Li, J., Song, W., Czerwinski, D. K., Varghese, B., Uematsu, S., & Levy, R. (2007). Lymphoma immunotherapy with CpG oligodeoxynucleotides requires TLR9 either in the host or in the tumor itself. JOURNAL OF IMMUNOLOGY, 179(4), 2493-2500.

Therapeutic vaccination against murine lymphoma by intratumoral injection of recombinant fowlpox virus encoding CD40 ligand
Liu, A., Guardino, A., Chinsangararn, L., Goldstein, M. J., Panicali, D., & Levy, R. (2007). Therapeutic vaccination against murine lymphoma by intratumoral injection of recombinant fowlpox virus encoding CD40 ligand. CANCER RESEARCH, 67(14), 7037-7044.

Cell-free production of scFv fusion proteins: an efficient approach for personalized lymphoma vaccines
Kanter, G., Yang, J., Voloshin, A., Levy, S., Swartz, J. R., & Levy, R. (2007). Cell-free production of scFv fusion proteins: an efficient approach for personalized lymphoma vaccines. BLOOD, 109(8), 3393-3399.

The oncoprotein LMO2 is expressed in normal germinal-center B cells and in human B-cell lymphomas
Natkunam, Y., Zhao, S., Mason, D. Y., Chen, J., Taidi, B., & Levy, R. (2007). The oncoprotein LMO2 is expressed in normal germinal-center B cells and in human B-cell lymphomas. BLOOD, 109(4), 1636-1642.

Expression of the RNA-binding protein VICKZ in normal hematopoietic tissues and neoplasms
Natkunam, Y., Vainer, G., Chen, J., Zhao, S., Marinelli, R. J., & Lossos, I. S. (2007). Expression of the RNA-binding protein VICKZ in normal hematopoietic tissues and neoplasms. HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 92(2), 176-183.

Humoral immune response and immunoglobulin G Fc receptor genotype are associated with better clinical outcome following idiotype vaccination in follicular lymphorna patients regardless of their response to induction chemotherapy
Weng, W.-K., Czerwinski, D., & Levy, R. (2007). Humoral immune response and immunoglobulin G Fc receptor genotype are associated with better clinical outcome following idiotype vaccination in follicular lymphorna patients regardless of their response to induction chemotherapy. BLOOD, 109(3), 951-953.

Expression of the human germinal center-associated lymphoma (HGAL) protein identifies a subset of classic Hodgkin lymphoma of germinal center derivation and improved survival
Natkunam, Y., Hsi, E. D., Aoun, P., Zhao, S., Elson, P., & Lossos, I. S. (2007). Expression of the human germinal center-associated lymphoma (HGAL) protein identifies a subset of classic Hodgkin lymphoma of germinal center derivation and improved survival. BLOOD, 109(1), 298-305.

Altered B-cell receptor signaling kinetics distinguish human follicular lymphoma. B cells from tumor-infiltrating nonmalignant B cells
Irish, J. M., Czerwinski, D. K., Nolan, G. P., & Levy, R. (2006). Altered B-cell receptor signaling kinetics distinguish human follicular lymphoma. B cells from tumor-infiltrating nonmalignant B cells. BLOOD, 108(9), 3135-3142.

Kinetics of B cell receptor signaling in human B cell subsets mapped by phosphospecific flow cytometry
Irish, J. M., Czerwinski, D. K., Nolan, G. P., & Levy, R. (2006). Kinetics of B cell receptor signaling in human B cell subsets mapped by phosphospecific flow cytometry. JOURNAL OF IMMUNOLOGY, 177(3), 1581-1589.

Production of myeloid dendritic cells (DC) pulsed with tumor-specific idiotype protein for vaccination of patients with multiple myeloma
Guardino, A. E., Rajapaksa, R., Ong, K. H., Sheehan, K., & Levy, R. (2006). Production of myeloid dendritic cells (DC) pulsed with tumor-specific idiotype protein for vaccination of patients with multiple myeloma. CYTOTHERAPY, 8(3), 277-289.

Therapeutic vaccination against murine lymphoma by intratumoral injection of naive dendritic cells
Song, W. R., & Levy, R. (2005). Therapeutic vaccination against murine lymphoma by intratumoral injection of naive dendritic cells. CANCER RESEARCH, 65(13), 5958-5964.

Expression of the human germinal center-associated lymphoma (HGAL) protein, a new marker of germinal center B-cell derivation
Natkunam, Y., Lossos, L. S., Taidi, B., Zhao, S. C., Lu, X. Q., & Levy, R. (2005). Expression of the human germinal center-associated lymphoma (HGAL) protein, a new marker of germinal center B-cell derivation. BLOOD, 105(10), 3979-3986.

Rapid expression of vaccine proteins for B-cell lymphoma in a cell-free system
Yang, J. H., Kanter, G., Voloshin, A., Michel-Reydellet, N., Velkeen, H., & Swartz, J. R. (2005). Rapid expression of vaccine proteins for B-cell lymphoma in a cell-free system. BIOTECHNOLOGY AND BIOENGINEERING, 89(5), 503-511.

The radioisotope contributes significantly to the activity of radioimmunotherapy
Davis, T. A., Kaminski, M. S., Leonard, J. P., Hsu, F. J., Wilkinson, M., & Knox, S. J. (2004). The radioisotope contributes significantly to the activity of radioimmunotherapy. CLINICAL CANCER RESEARCH, 10(23), 7792-7798.

Clinical outcome of lymphoma patients after idiotype vaccination is correlated with humoral immune response and immunoglobulin G Fc receptor genotype
Weng, W. K., Czerwinski, D., Timmerman, J., Hsu, F. J., & Levy, R. (2004). Clinical outcome of lymphoma patients after idiotype vaccination is correlated with humoral immune response and immunoglobulin G Fc receptor genotype. JOURNAL OF CLINICAL ONCOLOGY, 22(23), 4717-4724.

Expression of active murine granulocyte-macrophage colony-stimulating factor in an Escherichia coli cell-free system
Yang, J. H., Kanter, G., Voloshin, A., Levy, R., & Swartz, J. R. (2004). Expression of active murine granulocyte-macrophage colony-stimulating factor in an Escherichia coli cell-free system. BIOTECHNOLOGY PROGRESS, 20(6), 1689-1696.

AID is expressed in germinal center B-cell-like and activated B-cell-like diffuse large-cell lymphomas and is not correlated with intraclonal heterogeneity
Lossos, I. S., Levy, R., & Alizadeh, A. A. (2004). AID is expressed in germinal center B-cell-like and activated B-cell-like diffuse large-cell lymphomas and is not correlated with intraclonal heterogeneity. LEUKEMIA, 18(11), 1775-1779.

Vaccines in lymphoma.
Levy, R. (2004). Vaccines in lymphoma. Clinical advances in hematology & oncology : H&O, 2(7), 424-?.

Prediction of survival in diffuse large-B-cell lymphoma based on the expression of six genes
Lossos, I. S., Czerwinski, D. K., Alizadeh, A. A., Wechser, M. A., Tibshirani, R., & Levy, R. (2004). Prediction of survival in diffuse large-B-cell lymphoma based on the expression of six genes. NEW ENGLAND JOURNAL OF MEDICINE, 350(18), 1828-1837.

Molecular rescue of tumour-specific T cell receptor idiotype from T cell lymphomas
Reddy, S. A., & Levy, R. (2004). Molecular rescue of tumour-specific T cell receptor idiotype from T cell lymphomas. BRITISH JOURNAL OF HAEMATOLOGY, 124(5), 626-628.

TCR vaccines against a murine T cell lymphoma: A primary role for antibodies of the IgG2c class in tumor protection
Lambert, S. L., Okada, C. Y., & Levy, R. (2004). TCR vaccines against a murine T cell lymphoma: A primary role for antibodies of the IgG2c class in tumor protection. JOURNAL OF IMMUNOLOGY, 172(2), 929-936.

Two immunoglobulin G fragment C receptor polymorphisms independently predict response to rituximab in patients with follicular lymphoma
Weng, W. K., & Levy, R. (2003). Two immunoglobulin G fragment C receptor polymorphisms independently predict response to rituximab in patients with follicular lymphoma. JOURNAL OF CLINICAL ONCOLOGY, 21(21), 3940-3947.

Multiple BCL6 translocation partners in individual cases of gastric lymphoma - Response
Lossos, I. S., Akasaka, T., & Levy, R. (2003). Multiple BCL6 translocation partners in individual cases of gastric lymphoma - Response. BLOOD, 102(5), 1932-1932.

BCL6 gene translocation in follicular lymphoma: a harbinger of eventual transformation to diffuse aggressive lymphoma
Akasaka, T., Lossos, I. S., & Levy, R. (2003). BCL6 gene translocation in follicular lymphoma: a harbinger of eventual transformation to diffuse aggressive lymphoma. BLOOD, 102(4), 1443-1448.

Analysis of FAS (CD95) gene mutations in higher-grade transformation of follicle center lymphoma
Do, B., Lossos, I. S., Thorstenson, Y., Oefner, P. J., & Levy, R. (2003). Analysis of FAS (CD95) gene mutations in higher-grade transformation of follicle center lymphoma. LEUKEMIA & LYMPHOMA, 44(8), 1317-1323.

The BCL6 gene in B-cell lymphomas with 3q27 translocations is expressed mainly from the rearranged allele irrespective of the partner gene
Lossos, I. S., Akasaka, T., Martinez-Climent, J. A., Siebert, R., & Levy, R. (2003). The BCL6 gene in B-cell lymphomas with 3q27 translocations is expressed mainly from the rearranged allele irrespective of the partner gene. LEUKEMIA, 17(7), 1390-1397.

Higher grade transformation of follicular lymphoma: phenotypic tumor progression associated with diverse genetic lesions
Lossos, I. S., & Levy, R. (2003). Higher grade transformation of follicular lymphoma: phenotypic tumor progression associated with diverse genetic lesions. SEMINARS IN CANCER BIOLOGY, 13(3), 191-202.

Diffuse large B-cell lymphoma: Insights gained from gene expression profiling
Lossos, I. S., & Levy, R. (2003). Diffuse large B-cell lymphoma: Insights gained from gene expression profiling. INTERNATIONAL JOURNAL OF HEMATOLOGY, 77(4), 321-329.

Antitumor immunity after vaccination with B lymphoma cells overexpressing a triad of costimulatory molecules
Briones, J., Timmerman, J. M., Panicalli, D. L., & Levy, R. (2003). Antitumor immunity after vaccination with B lymphoma cells overexpressing a triad of costimulatory molecules. JOURNAL OF THE NATIONAL CANCER INSTITUTE, 95(7), 548-555.

Optimization of quantitative real-time RT-PCR parameters for the study of lymphoid malignancies
Levy, R. (2003). Optimization of quantitative real-time RT-PCR parameters for the study of lymphoid malignancies. LEUKEMIA, 17(4), 796-797.

Optimization of quantitative real-time RT-PCR parameters for the study of lymphoid malignancies
Lossos, I. S., Czerwinski, D. K., Wechser, M. A., & Levy, R. (2003). Optimization of quantitative real-time RT-PCR parameters for the study of lymphoid malignancies. LEUKEMIA, 17(4), 789-795.

Variation in gene expression patterns in follicular lymphoma and the response to rituximab
Bohen, S. P., Troyanskaya, O. G., Alter, O., Warnke, R., Botstein, D., & Levy, R. (2003). Variation in gene expression patterns in follicular lymphoma and the response to rituximab. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 100(4), 1926-1930.

HGAL is a novel interleukin-4-inducible gene that strongly predicts survival in diffuse large B-cell lymphoma
Lossos, I. S., Alizadeh, A. A., Rajapaksa, R., Tibshirani, R., & Levy, R. (2003). HGAL is a novel interleukin-4-inducible gene that strongly predicts survival in diffuse large B-cell lymphoma. BLOOD, 101(2), 433-440.

Immunogenicity of a plasmid DNA vaccine encoding chimeric idiotype in patients with B-cell lymphoma
Timmerman, J. M., Singh, G., Hermanson, G., Hobart, P., Czerwinski, D. K., & Levy, R. (2002). Immunogenicity of a plasmid DNA vaccine encoding chimeric idiotype in patients with B-cell lymphoma. CANCER RESEARCH, 62(20), 5845-5852.

BCL-6 mRNA expression in higher grade transformation of follicle center lymphoma: correlation with somatic mutations in the 5 ' regulatory region of the BCL-6 gene
Lossos, I. S., Warnke, R., & Levy, R. (2002). BCL-6 mRNA expression in higher grade transformation of follicle center lymphoma: correlation with somatic mutations in the 5 ' regulatory region of the BCL-6 gene. LEUKEMIA, 16(9), 1857-1862.

Transformation of follicular lymphoma to diffuse large-cell lymphoma: Alternative patterns with increased or decreased expression of c-myc and its regulated genes
Lossos, I. S., Alizadeh, A. A., Diehn, M., Warnke, R., Thorstenson, Y., & Levy, R. (2002). Transformation of follicular lymphoma to diffuse large-cell lymphoma: Alternative patterns with increased or decreased expression of c-myc and its regulated genes. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 99(13), 8886-8891.

In vivo antitumor effect of CD40L-transduced tumor cells as a vaccine for B-cell lymphoma
Briones, J., Timmerman, J., & Levy, R. (2002). In vivo antitumor effect of CD40L-transduced tumor cells as a vaccine for B-cell lymphoma. CANCER RESEARCH, 62(11), 3195-3199.

Mutation of the ATM gene is not involved in the pathogenesis of either follicle center lymphoma or its transformation to higher-grade lymphoma
Lossos, I. S., Thorstenson, Y. R., Wayne, T. L., Oefner, P. J., Levy, R., & Chu, G. (2002). Mutation of the ATM gene is not involved in the pathogenesis of either follicle center lymphoma or its transformation to higher-grade lymphoma. LEUKEMIA & LYMPHOMA, 43(5), 1079-1085.

Idiotype-pulsed dendritic cell vaccination for B-cell lymphoma: clinical and immune responses in 35 patients
Timmerman, J. M., Czerwinski, D. K., Davis, T. A., Hsu, F. J., Benike, C., & Levy, R. (2002). Idiotype-pulsed dendritic cell vaccination for B-cell lymphoma: clinical and immune responses in 35 patients. BLOOD, 99(5), 1517-1526.

Rapid establishment of dendritic cell chimerism in allogeneic hematopoietic cell transplant recipients
Auffermann-Gretzinger, S., Lossos, I. S., Vayntrub, T. A., Leong, W., GRUMET, F. C., & Shizuru, J. A. (2002). Rapid establishment of dendritic cell chimerism in allogeneic hematopoietic cell transplant recipients. BLOOD, 99(4), 1442-1448.

BLyS* and BLyS receptor expression in non-Hodgkin's lymphoma
Briones, J., Timmerman, J. M., Hilbert, D. M., & Levy, R. (2002). BLyS* and BLyS receptor expression in non-Hodgkin's lymphoma. EXPERIMENTAL HEMATOLOGY, 30(2), 135-141.

Apoptosis stimulating protein of p53 (ASPP2) expression differs in diffuse large B-cell and follicular center lymphoma: Correlation with clinical outcome
Lossos, I. S., Natkunam, Y., Levy, R., & Lopez, C. D. (2002). Apoptosis stimulating protein of p53 (ASPP2) expression differs in diffuse large B-cell and follicular center lymphoma: Correlation with clinical outcome. LEUKEMIA & LYMPHOMA, 43(12), 2309-2317.

A polymorphism in the BCL-6 gene is associated with follicle center lymphoma
Lossos, I. S., Jones, C. D., Zehnder, J. L., & Levy, R. (2001). A polymorphism in the BCL-6 gene is associated with follicle center lymphoma. LEUKEMIA & LYMPHOMA, 42(6), 1343-1350.

Re: Akasaka, H., et al., Molecular anatomy of BCL6 translocations revealed by long-distance polymerase chain reaction-based assays. Cancer Res., 60: 2335-2341, 2000.
Lossos, I. S., Jacobs, Y., Cleary, M. L., & Levy, R. (2001). Re: Akasaka, H., et al., Molecular anatomy of BCL6 translocations revealed by long-distance polymerase chain reaction-based assays. Cancer Res., 60: 2335-2341, 2000. Cancer research, 61(19), 7363-7364.

Expression of complement inhibitors CD46, CD55, and CD59 on tumor cells does not predict clinical outcome after rituximab treatment in follicular non-Hodgkin lymphoma
Weng, W. K., & Levy, R. (2001). Expression of complement inhibitors CD46, CD55, and CD59 on tumor cells does not predict clinical outcome after rituximab treatment in follicular non-Hodgkin lymphoma. BLOOD, 98(5), 1352-1357.

Expression of a single gene, BCL-6, strongly predicts survival in patients with diffuse large B-cell lymphoma
Lossos, I. S., Jones, C. D., Warnke, R., Natkunam, Y., Kaizer, H., & Levy, R. (2001). Expression of a single gene, BCL-6, strongly predicts survival in patients with diffuse large B-cell lymphoma. BLOOD, 98(4), 945-951.

Idiotype-encoding recombinant adenoviruses provide protective immunity against murine B-cell lymphomas
Timmerman, J. M., Caspar, C. B., Lambert, S. L., Syrengelas, A. D., & Levy, R. (2001). Idiotype-encoding recombinant adenoviruses provide protective immunity against murine B-cell lymphomas. BLOOD, 97(5), 1370-1377.

T cell antigen receptor vaccines for active therapy of T cell malignancies
Reddy, S. A., Okada, C., Wong, C., Bahler, D., & Levy, R. (2001). T cell antigen receptor vaccines for active therapy of T cell malignancies. CUTANEOUS T CELL LYMPHOMA: BASIC AND CLINICALLY RELEVANT BIOLOGY, 941, 97-105.

Idiotype vaccination following ABMT can stimulate specific anti-idiotype immune responses in patients with B-cell lymphoma
Davis, T. A., Hsu, F. J., Caspar, C. B., van Beckhoven, A., Czerwinski, D. K., & Levy, R. (2001). Idiotype vaccination following ABMT can stimulate specific anti-idiotype immune responses in patients with B-cell lymphoma. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 7(9), 517-522.

The inference of antigen selection on Ig genes
Lossos, I. S., Tibshirani, R., Narasimhan, B., & Levy, R. (2000). The inference of antigen selection on Ig genes. JOURNAL OF IMMUNOLOGY, 165(9), 5122-5126.

A perspective on monoclonal antibody therapy: Where we have been and where we are going
Levy, R. (2000). A perspective on monoclonal antibody therapy: Where we have been and where we are going. SEMINARS IN HEMATOLOGY, 37(4), 43-46.

The history of the development of vaccines for the treatment of lymphoma.
Timmerman, J. M., & Levy, R. (2000). The history of the development of vaccines for the treatment of lymphoma. Clinical lymphoma, 1(2), 129-139.

Rituximab anti-CD20 monoclonal antibody therapy in non-Hodgkin's lymphoma: Safety and efficacy of re-treatment
Davis, T. A., Grillo-Lopez, A. J., White, C. A., McLaughlin, P., Czuczman, M. S., & Levy, R. (2000). Rituximab anti-CD20 monoclonal antibody therapy in non-Hodgkin's lymphoma: Safety and efficacy of re-treatment. JOURNAL OF CLINICAL ONCOLOGY, 18(17), 3135-3143.

Ongoing immunoglobulin somatic mutation in germinal center B cell-like but not in activated B cell-like diffuse large cell lymphomas
Lossos, I. S., Alizadeh, A. A., Eisen, M. B., Chan, W. C., Brown, P. O., & Levy, R. (2000). Ongoing immunoglobulin somatic mutation in germinal center B cell-like but not in activated B cell-like diffuse large cell lymphomas. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 97(18), 10209-10213.

Higher-grade transformation of follicle center lymphoma is associated with somatic mutation of the 5 ' noncoding regulatory region of the BCL-6 gene
Lossos, I. S., & Levy, R. (2000). Higher-grade transformation of follicle center lymphoma is associated with somatic mutation of the 5 ' noncoding regulatory region of the BCL-6 gene. BLOOD, 96(2), 635-639.

Combination immunotherapy of relapsed or refractory low-grade or follicular non-Hodgkin's lymphoma with rituximab and interferon-alpha-2a
Davis, T. A., Maloney, D. G., Grillo-Lopez, A. J., White, C. A., Williams, M. E., & Levy, R. (2000). Combination immunotherapy of relapsed or refractory low-grade or follicular non-Hodgkin's lymphoma with rituximab and interferon-alpha-2a. CLINICAL CANCER RESEARCH, 6(7), 2644-2652.

Recombinant adenovirus vaccine encoding a chimeric T-cell antigen receptor induces protective immunity against a T-cell lymphoma
Wong, C. P., & Levy, R. (2000). Recombinant adenovirus vaccine encoding a chimeric T-cell antigen receptor induces protective immunity against a T-cell lymphoma. CANCER RESEARCH, 60(10), 2689-2695.

Linkage of foreign carrier protein to a self-tumor antigen enhances the immunogenicity of a pulsed dendritic cell vaccine
Timmerman, J. M., & Levy, R. (2000). Linkage of foreign carrier protein to a self-tumor antigen enhances the immunogenicity of a pulsed dendritic cell vaccine. JOURNAL OF IMMUNOLOGY, 164(9), 4797-4803.

Molecular analysis of immunoglobulin genes in diffuse large B-cell lymphomas
Lossos, I. S., Okada, C. Y., Tibshirani, R., Warnke, R., Vose, J. M., & Levy, R. (2000). Molecular analysis of immunoglobulin genes in diffuse large B-cell lymphomas. BLOOD, 95(5), 1797-1803.

Mutation analysis of the 5 ' noncoding regulatory region of the BCL-6 gene in non-Hodgkin lymphoma: evidence for recurrent mutations and intraclonal heterogeneity
Lossos, I. S., & Levy, R. (2000). Mutation analysis of the 5 ' noncoding regulatory region of the BCL-6 gene in non-Hodgkin lymphoma: evidence for recurrent mutations and intraclonal heterogeneity. BLOOD, 95(4), 1400-1405.

Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling
Alizadeh, A. A., Eisen, M. B., Davis, R. E., Ma, C., Lossos, I. S., & Staudt, L. M. (2000). Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling. NATURE, 403(6769), 503-511.

Idiotype vaccination using dendritic cells after autologous peripheral blood progenitor cell transplantation for multiple myeloma
Liso, A., Stockerl-Goldstein, K. E., Auffermann-Gretzinger, S., Benike, C. J., Reichardt, V., & Levy, R. (2000). Idiotype vaccination using dendritic cells after autologous peripheral blood progenitor cell transplantation for multiple myeloma. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 6(6), 621-627.

Cytokine fusion constructs as DNA vaccines against tumors.
Maecker, H. T., Syrengelas, A., & Levy, R. (2000). Cytokine fusion constructs as DNA vaccines against tumors. Methods in molecular medicine, 29, 221-239.

'Gene shaving' as a method for identifying distinct sets of genes with similar expression patterns.
Hastie, T., Tibshirani, R., Eisen, M. B., Alizadeh, A., Levy, R., & BROWN, P. (2000). 'Gene shaving' as a method for identifying distinct sets of genes with similar expression patterns. Genome biology, 1(2), RESEARCH0003-?.

Karnofsky Lecture: Immunotherapy of lymphoma
Levy, R. (1999). Karnofsky Lecture: Immunotherapy of lymphoma. JOURNAL OF CLINICAL ONCOLOGY, 17(11), 7-12.

1999 keystone symposium on B lymphocyte biology and disease: B cell malignancy II session.
Levy, R. (1999). 1999 keystone symposium on B lymphocyte biology and disease: B cell malignancy II session. Biochimica et biophysica acta, 1424(2-3), R43-4.

Single-agent monoclonal antibody efficacy in bulky non-Hodgkin's lymphoma: Results of a phase II trial of rituximab
Davis, T. A., White, C. A., Grillo-Lopez, A. J., Velasquez, W. S., Link, B., & Levy, R. (1999). Single-agent monoclonal antibody efficacy in bulky non-Hodgkin's lymphoma: Results of a phase II trial of rituximab. JOURNAL OF CLINICAL ONCOLOGY, 17(6), 1851-1857.

DNA vaccination against the idiotype of a murine B cell lymphoma: Mechanism of tumor protection
Syrengelas, A. D., & Levy, R. (1999). DNA vaccination against the idiotype of a murine B cell lymphoma: Mechanism of tumor protection. JOURNAL OF IMMUNOLOGY, 162(8), 4790-4795.

Idiotype vaccination using dendritic cells after autologous peripheral blood stem cell transplantation for multiple myeloma - A feasibility study
Reichardt, V. L., Okada, C. Y., Liso, A., Benike, C. J., Stockerl-Goldstein, K. E., & Levy, R. (1999). Idiotype vaccination using dendritic cells after autologous peripheral blood stem cell transplantation for multiple myeloma - A feasibility study. BLOOD, 93(7), 2411-2419.

TCR vaccines against T cell lymphoma: QS-21 and IL-12 adjuvants induce a protective CD8(+) T cell response
Wong, C. P., Okada, C. Y., & Levy, R. (1999). TCR vaccines against T cell lymphoma: QS-21 and IL-12 adjuvants induce a protective CD8(+) T cell response. JOURNAL OF IMMUNOLOGY, 162(4), 2251-2258.

Dendritic cell vaccines for cancer immunotherapy
Timmerman, J. M., & Levy, R. (1999). Dendritic cell vaccines for cancer immunotherapy. ANNUAL REVIEW OF MEDICINE, 50, 507-529.

Anti-idiotype antibodies can induce long-term complete remissions in non-Hodgkin's lymphoma without eradicating the malignant clone
Davis, T. A., Maloney, D. G., Czerwinski, D. K., Liles, T. M., & Levy, R. (1998). Anti-idiotype antibodies can induce long-term complete remissions in non-Hodgkin's lymphoma without eradicating the malignant clone. BLOOD, 92(4), 1184-1190.

Stereotactic radiosurgery of angiographically occult vascular malformations: 14-year experience
Chang, S. D., Levy, R. P., Adler, J. R., Martin, D. P., Krakovitz, P. R., & Steinberg, G. K. (1998). Stereotactic radiosurgery of angiographically occult vascular malformations: 14-year experience. NEUROSURGERY, 43(2), 213-220.

Pathological changes in surgically resected angiographically occult vascular malformations after radiation
Gewirtz, R. J., Steinberg, G. K., Crowley, R., & Levy, R. P. (1998). Pathological changes in surgically resected angiographically occult vascular malformations after radiation. NEUROSURGERY, 42(4), 738-742.

Identification of peptide ligands for the antigen binding receptor expressed on human B-cell lymphomas.
Renschler, M. F., Dower, W. J., & Levy, R. (1998). Identification of peptide ligands for the antigen binding receptor expressed on human B-cell lymphomas. Methods in molecular biology (Clifton, N.J.), 87, 209-234.

TCR vaccines for active immunotherapy of T cell malignancies
Okada, C. Y., Wong, C. P., Denney, D. W., & Levy, R. (1997). TCR vaccines for active immunotherapy of T cell malignancies. JOURNAL OF IMMUNOLOGY, 159(11), 5516-5527.

Idiotype vaccines for non-Hodgkin's lymphoma induce polyclonal immune responses that cover mutated tumor idiotypes: Comparison of different vaccine formulations
Caspar, C. B., Levy, S., & Levy, R. (1997). Idiotype vaccines for non-Hodgkin's lymphoma induce polyclonal immune responses that cover mutated tumor idiotypes: Comparison of different vaccine formulations. BLOOD, 90(9), 3699-3706.

IDEC-C2B8: Results of a phase I multiple-dose trial in patients with relapsed non-Hodgkin's lymphoma
Maloney, D. G., GRILLOLOPEZ, A. J., Bodkin, D. J., White, C. A., Liles, T. M., & Levy, R. (1997). IDEC-C2B8: Results of a phase I multiple-dose trial in patients with relapsed non-Hodgkin's lymphoma. JOURNAL OF CLINICAL ONCOLOGY, 15(10), 3266-3274.

IDEC-C2B8 (Rituximab) anti-CD20 monoclonal antibody therapy in patients with relapsed low-grade non-Hodgkin's lymphoma
Maloney, D. G., GRILLOLOPEZ, A. J., White, C. A., Bodkin, D., Schilder, R. J., & Levy, R. (1997). IDEC-C2B8 (Rituximab) anti-CD20 monoclonal antibody therapy in patients with relapsed low-grade non-Hodgkin's lymphoma. BLOOD, 90(6), 2188-2195.

Rationale for adjuvant idiotypic vaccination after high-dose therapy for multiple myeloma.
Reichardt, V. L., Okada, C. Y., Stockerl-Goldstein, K. E., Bogen, B., & Levy, R. (1997). Rationale for adjuvant idiotypic vaccination after high-dose therapy for multiple myeloma. Biology of blood and marrow transplantation , 3(3), 157-163.

Tumor-specific idiotype vaccines in the treatment of patients with B-cell lymphoma - Long-term results of a clinical trial
Hsu, F. J., Caspar, C. B., Czerwinski, D., Kwak, L. W., Liles, T. M., & Levy, R. (1997). Tumor-specific idiotype vaccines in the treatment of patients with B-cell lymphoma - Long-term results of a clinical trial. BLOOD, 89(9), 3129-3135.

A nine-amino acid peptide from IL-1 beta augments antitumor immune responses induced by protein and DNA vaccines
Hakim, I., Levy, S., & Levy, R. (1996). A nine-amino acid peptide from IL-1 beta augments antitumor immune responses induced by protein and DNA vaccines. JOURNAL OF IMMUNOLOGY, 157(12), 5503-5511.

DNA immunization induces protective immunity against B-cell lymphoma
Syrengelas, A. D., Chen, T. T., & Levy, R. (1996). DNA immunization induces protective immunity against B-cell lymphoma. NATURE MEDICINE, 2(9), 1038-1041.

Tumor-specific, cytotoxic T-lymphocyte response after idiotype vaccination for B-cell, non-Hodgkin's lymphoma
Nelson, E. L., Li, X. B., Hsu, F. J., Kwak, L. W., Levy, R., & KRENSKY, A. M. (1996). Tumor-specific, cytotoxic T-lymphocyte response after idiotype vaccination for B-cell, non-Hodgkin's lymphoma. BLOOD, 88(2), 580-589.

Surgical resection of large incompletely treated intracranial arteriovenous malformations following stereotactic radiosurgery
Steinberg, G. K., Chang, S. D., Levy, R. P., Marks, M. P., Frankel, K., & Marcellus, M. (1996). Surgical resection of large incompletely treated intracranial arteriovenous malformations following stereotactic radiosurgery. JOURNAL OF NEUROSURGERY, 84(6), 920-928.

Yttrium-90-labeled anti-CD20 monoclonal antibody therapy of recurrent B-cell lymphoma
Knox, S. J., Goris, M. L., Trisler, K., Negrin, R., Davis, T., & Levy, R. (1996). Yttrium-90-labeled anti-CD20 monoclonal antibody therapy of recurrent B-cell lymphoma. CLINICAL CANCER RESEARCH, 2(3), 457-470.

Treatment of cutaneous T-Cell lymphoma with chimeric anti-CD4 monoclonal antibody
Knox, S., Hoppe, R. T., Maloney, D., Gibbs, I., Fowler, S., & Levy, R. (1996). Treatment of cutaneous T-Cell lymphoma with chimeric anti-CD4 monoclonal antibody. BLOOD, 87(3), 893-899.

Vaccination of patients with B-cell lymphoma using autologous antigen-pulsed dendritic cells
Hsu, F. J., Benike, C., Fagnoni, F., Liles, T. M., Czerwinski, D., & Levy, R. (1996). Vaccination of patients with B-cell lymphoma using autologous antigen-pulsed dendritic cells. NATURE MEDICINE, 2(1), 52-58.

B-LYMPHOMA CELLS ARE ACTIVATED BY PEPTIDE LIGANDS OF THE ANTIGEN-BINDING RECEPTOR OR BY ANTIIDIOTYPIC ANTIBODY TO INDUCE EXTRACELLULAR ACIDIFICATION
Renschler, M. F., Wada, H. G., Fok, K. S., & Levy, R. (1995). B-LYMPHOMA CELLS ARE ACTIVATED BY PEPTIDE LIGANDS OF THE ANTIGEN-BINDING RECEPTOR OR BY ANTIIDIOTYPIC ANTIBODY TO INDUCE EXTRACELLULAR ACIDIFICATION. CANCER RESEARCH, 55(23), 5642-5647.

PREFERENTIAL USE OF THE VH4 IG GENE FAMILY BY DIFFUSE LARGE-CELL LYMPHOMA
Hsu, F. J., & Levy, R. (1995). PREFERENTIAL USE OF THE VH4 IG GENE FAMILY BY DIFFUSE LARGE-CELL LYMPHOMA. BLOOD, 86(8), 3072-3082.

INDUCTION OF AUTOANTIBODY RESPONSES TO GM-CSF BY HYPERIMMUNIZATION WITH AN ID-GM-CSF FUSION PROTEIN
Chen, T. T., & Levy, R. (1995). INDUCTION OF AUTOANTIBODY RESPONSES TO GM-CSF BY HYPERIMMUNIZATION WITH AN ID-GM-CSF FUSION PROTEIN. JOURNAL OF IMMUNOLOGY, 154(7), 3105-3117.

IDIOTYPE-CYTOKINE FUSION PROTEINS AS CANCER VACCINES - RELATIVE EFFICACY OF IL-2, IL-4, AND GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR
Chen, T. T., Tao, M. H., & Levy, R. (1994). IDIOTYPE-CYTOKINE FUSION PROTEINS AS CANCER VACCINES - RELATIVE EFFICACY OF IL-2, IL-4, AND GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR. JOURNAL OF IMMUNOLOGY, 153(10), 4775-4787.

PHASE-I CLINICAL-TRIAL USING ESCALATING SINGLE-DOSE INFUSION OF CHIMERIC ANTI-CD20 MONOCLONAL-ANTIBODY (IDEC-C2B8) IN PATIENTS WITH RECURRENT B-CELL LYMPHOMA
Maloney, D. G., Liles, T. M., Czerwinski, D. K., WALDICHUK, C., Rosenberg, J., & Levy, R. (1994). PHASE-I CLINICAL-TRIAL USING ESCALATING SINGLE-DOSE INFUSION OF CHIMERIC ANTI-CD20 MONOCLONAL-ANTIBODY (IDEC-C2B8) IN PATIENTS WITH RECURRENT B-CELL LYMPHOMA. BLOOD, 84(8), 2457-2466.

SYNTHETIC PEPTIDE LIGANDS OF THE ANTIGEN-BINDING RECEPTOR INDUCE PROGRAMMED CELL-DEATH IN A HUMAN B-CELL LYMPHOMA
Renschler, M. F., Bhatt, R. R., Dower, W. J., & Levy, R. (1994). SYNTHETIC PEPTIDE LIGANDS OF THE ANTIGEN-BINDING RECEPTOR INDUCE PROGRAMMED CELL-DEATH IN A HUMAN B-CELL LYMPHOMA. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 91(9), 3623-3627.

LYMPHOMA REGRESSION INDUCED BY MONOCLONAL ANTIIDIOTYPIC ANTIBODIES CORRELATES WITH THEIR ABILITY TO INDUCE IG SIGNAL-TRANSDUCTION AND IS NOT PREVENTED BY TUMOR EXPRESSION OF HIGH-LEVELS OF BCL-2 PROTEIN
Vuist, W. Mj., Levy, R., & Maloney, D. G. (1994). LYMPHOMA REGRESSION INDUCED BY MONOCLONAL ANTIIDIOTYPIC ANTIBODIES CORRELATES WITH THEIR ABILITY TO INDUCE IG SIGNAL-TRANSDUCTION AND IS NOT PREVENTED BY TUMOR EXPRESSION OF HIGH-LEVELS OF BCL-2 PROTEIN. BLOOD, 83(4), 899-906.

CELL DYN-3000 AND COULTER STKS AUTOMATED DIFFERENTIAL COUNTERS - REPLY
Cornbleet, P. J., Myrick, D., Levy, R., & JUDKINS, S. (1993). CELL DYN-3000 AND COULTER STKS AUTOMATED DIFFERENTIAL COUNTERS - REPLY. AMERICAN JOURNAL OF CLINICAL PATHOLOGY, 100(4), 464-465.

TRANSFORMATION OF MYCOSIS-FUNGOIDES - T-CELL RECEPTOR-BETA GENE ANALYSIS DEMONSTRATES A COMMON CLONAL ORIGIN FOR PLAQUE-TYPE MYCOSIS-FUNGOIDES AND CD30+ LARGE-CELL LYMPHOMA
Wood, G. S., Bahler, D. W., Hoppe, R. T., Warnke, R. A., Sklar, J. L., & Levy, R. (1993). TRANSFORMATION OF MYCOSIS-FUNGOIDES - T-CELL RECEPTOR-BETA GENE ANALYSIS DEMONSTRATES A COMMON CLONAL ORIGIN FOR PLAQUE-TYPE MYCOSIS-FUNGOIDES AND CD30+ LARGE-CELL LYMPHOMA. JOURNAL OF INVESTIGATIVE DERMATOLOGY, 101(3), 296-300.

CLINICAL-TRIALS OF IDIOTYPE-SPECIFIC VACCINE IN B-CELL LYMPHOMAS
Hsu, F. J., Kwak, L., Campbell, M., LILES, T., Czerwinski, D., & Levy, R. (1993). CLINICAL-TRIALS OF IDIOTYPE-SPECIFIC VACCINE IN B-CELL LYMPHOMAS. ANNALS OF THE NEW YORK ACADEMY OF SCIENCES, 690, 385-387.

IDIOTYPE GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR FUSION PROTEIN AS A VACCINE FOR B-CELL LYMPHOMA
Tao, M. H., & Levy, R. (1993). IDIOTYPE GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR FUSION PROTEIN AS A VACCINE FOR B-CELL LYMPHOMA. NATURE, 362(6422), 755-758.

ENDOVASCULAR TREATMENT OF CEREBRAL ARTERIOVENOUS-MALFORMATIONS FOLLOWING RADIOSURGERY
Marks, M. P., Lane, B., Steinberg, G. K., FABRIKANT, J. I., Levy, R. P., & Phillips, M. H. (1993). ENDOVASCULAR TREATMENT OF CEREBRAL ARTERIOVENOUS-MALFORMATIONS FOLLOWING RADIOSURGERY. AMERICAN JOURNAL OF NEURORADIOLOGY, 14(2), 297-303.

A SUBMICROSCOPIC INTERSTITIAL DELETION OF CHROMOSOME-14 FREQUENTLY OCCURS ADJACENT TO THE T(14 18) TRANSLOCATION BREAKPOINT IN HUMAN FOLLICULAR LYMPHOMA
Zelenetz, A. D., Cleary, M. L., & Levy, R. (1993). A SUBMICROSCOPIC INTERSTITIAL DELETION OF CHROMOSOME-14 FREQUENTLY OCCURS ADJACENT TO THE T(14 18) TRANSLOCATION BREAKPOINT IN HUMAN FOLLICULAR LYMPHOMA. GENES CHROMOSOMES & CANCER, 6(3), 140-150.

EVALUATION OF THE COULTER STKS 5-PART DIFFERENTIAL
Cornbleet, P. J., Myrick, D., & Levy, R. (1993). EVALUATION OF THE COULTER STKS 5-PART DIFFERENTIAL. AMERICAN JOURNAL OF CLINICAL PATHOLOGY, 99(1), 72-81.

EVALUATION OF THE CELL-DYN 3000 DIFFERENTIAL
Cornbleet, P. J., Myrick, D., JUDKINS, S., & Levy, R. (1992). EVALUATION OF THE CELL-DYN 3000 DIFFERENTIAL. AMERICAN JOURNAL OF CLINICAL PATHOLOGY, 98(6), 603-614.

INDUCTION OF IMMUNE-RESPONSES IN PATIENTS WITH B-CELL LYMPHOMA AGAINST THE SURFACE-IMMUNOGLOBULIN IDIOTYPE EXPRESSED BY THEIR TUMORS
Kwak, L. W., Campbell, M. J., Czerwinski, D. K., Hart, S., MILLER, R. A., & Levy, R. (1992). INDUCTION OF IMMUNE-RESPONSES IN PATIENTS WITH B-CELL LYMPHOMA AGAINST THE SURFACE-IMMUNOGLOBULIN IDIOTYPE EXPRESSED BY THEIR TUMORS. NEW ENGLAND JOURNAL OF MEDICINE, 327(17), 1209-1215.

CLONAL EXPANSION IN FOLLICULAR LYMPHOMA OCCURS SUBSEQUENT TO ANTIGENIC SELECTION
Zelenetz, A. D., Chen, T. T., & Levy, R. (1992). CLONAL EXPANSION IN FOLLICULAR LYMPHOMA OCCURS SUBSEQUENT TO ANTIGENIC SELECTION. JOURNAL OF EXPERIMENTAL MEDICINE, 176(4), 1137-1148.

Antigen selection in human lymphomagenesis.
Bahler, D. W., Zelenetz, A. D., Chen, T. T., & Levy, R. (1992). Antigen selection in human lymphomagenesis. Cancer research, 52(19), 5547s-5551s.

MONOCLONAL ANTIIDIOTYPE ANTIBODY THERAPY OF B-CELL LYMPHOMA - THE ADDITION OF A SHORT COURSE OF CHEMOTHERAPY DOES NOT INTERFERE WITH THE ANTITUMOR EFFECT NOR PREVENT THE EMERGENCE OF IDIOTYPE-NEGATIVE VARIANT CELLS
Maloney, D. G., Brown, S., Czerwinski, D. K., Liles, T. M., Hart, S. M., & Levy, R. (1992). MONOCLONAL ANTIIDIOTYPE ANTIBODY THERAPY OF B-CELL LYMPHOMA - THE ADDITION OF A SHORT COURSE OF CHEMOTHERAPY DOES NOT INTERFERE WITH THE ANTITUMOR EFFECT NOR PREVENT THE EMERGENCE OF IDIOTYPE-NEGATIVE VARIANT CELLS. BLOOD, 80(6), 1502-1510.

CLONAL EVOLUTION OF A FOLLICULAR LYMPHOMA - EVIDENCE FOR ANTIGEN SELECTION
Bahler, D. W., & Levy, R. (1992). CLONAL EVOLUTION OF A FOLLICULAR LYMPHOMA - EVIDENCE FOR ANTIGEN SELECTION. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 89(15), 6770-6774.

TUMOR RESISTANCE INDUCED BY SYNGENEIC BONE-MARROW TRANSPLANTATION AND ENHANCED BY INTERLEUKIN-2 - A MODEL FOR THE GRAFT VERSUS LEUKEMIA REACTION
Kwak, L. W., Campbell, M. J., & Levy, R. (1992). TUMOR RESISTANCE INDUCED BY SYNGENEIC BONE-MARROW TRANSPLANTATION AND ENHANCED BY INTERLEUKIN-2 - A MODEL FOR THE GRAFT VERSUS LEUKEMIA REACTION. CANCER RESEARCH, 52(15), 4117-4120.

INTERLEUKIN-3 IS A GROWTH-FACTOR FOR HUMAN FOLLICULAR B-CELL LYMPHOMA
CLAYBERGER, C., LUNAFINEMAN, S., Lee, J. E., Pillai, A., Campbell, M., & KRENSKY, A. M. (1992). INTERLEUKIN-3 IS A GROWTH-FACTOR FOR HUMAN FOLLICULAR B-CELL LYMPHOMA. JOURNAL OF EXPERIMENTAL MEDICINE, 175(2), 371-376.

USE OF FAMILY SPECIFIC LEADER REGION PRIMERS FOR PCR AMPLIFICATION OF THE HUMAN HEAVY-CHAIN VARIABLE REGION GENE REPERTOIRE
Campbell, M. J., Zelenetz, A. D., Levy, S., & Levy, R. (1992). USE OF FAMILY SPECIFIC LEADER REGION PRIMERS FOR PCR AMPLIFICATION OF THE HUMAN HEAVY-CHAIN VARIABLE REGION GENE REPERTOIRE. MOLECULAR IMMUNOLOGY, 29(2), 193-203.

DIVERSITY OF T-CELL ANTIGEN RECEPTOR VARIABLE GENES USED BY MYCOSIS-FUNGOIDES CELLS
Bahler, D. W., Berry, G., Oksenberg, J., Warnke, R. A., & Levy, R. (1992). DIVERSITY OF T-CELL ANTIGEN RECEPTOR VARIABLE GENES USED BY MYCOSIS-FUNGOIDES CELLS. AMERICAN JOURNAL OF PATHOLOGY, 140(1), 1-8.

TRANSFER OF SPECIFIC IMMUNITY TO B-CELL LYMPHOMA WITH SYNGENEIC BONE-MARROW IN MICE - A STRATEGY FOR USING AUTOLOGOUS MARROW AS AN ANTITUMOR THERAPY
Kwak, L. W., Campbell, M. J., Zelenetz, A. D., & Levy, R. (1991). TRANSFER OF SPECIFIC IMMUNITY TO B-CELL LYMPHOMA WITH SYNGENEIC BONE-MARROW IN MICE - A STRATEGY FOR USING AUTOLOGOUS MARROW AS AN ANTITUMOR THERAPY. BLOOD, 78(10), 2768-2772.

IG VH GENE-EXPRESSION AMONG HUMAN FOLLICULAR LYMPHOMAS
Bahler, D. W., Campbell, M. J., Hart, S., MILLER, R. A., Levy, S., & Levy, R. (1991). IG VH GENE-EXPRESSION AMONG HUMAN FOLLICULAR LYMPHOMAS. BLOOD, 78(6), 1561-1568.

ENHANCED DETECTION OF THE T(14-18) TRANSLOCATION IN MALIGNANT-LYMPHOMA USING PULSED-FIELD GEL-ELECTROPHORESIS
Zelenetz, A. D., Chu, G., Galili, N., Bangs, C. D., Horning, S. J., & Levy, R. (1991). ENHANCED DETECTION OF THE T(14-18) TRANSLOCATION IN MALIGNANT-LYMPHOMA USING PULSED-FIELD GEL-ELECTROPHORESIS. BLOOD, 78(6), 1552-1560.

AN EPITOPE ON THE TRANSFERRIN RECEPTOR PREFERENTIALLY EXPOSED DURING TUMOR PROGRESSION IN HUMAN LYMPHOMA IS CLOSE TO THE LIGAND-BINDING SITE
Takahashi, S., Esserman, L., & Levy, R. (1991). AN EPITOPE ON THE TRANSFERRIN RECEPTOR PREFERENTIALLY EXPOSED DURING TUMOR PROGRESSION IN HUMAN LYMPHOMA IS CLOSE TO THE LIGAND-BINDING SITE. BLOOD, 77(4), 826-832.

AN EXPERIMENTAL COMPARTMENTAL FLOW MODEL FOR ASSESSING THE HEMODYNAMIC-RESPONSE OF INTRACRANIAL ARTERIOVENOUS-MALFORMATIONS TO STEREOTAXIC RADIOSURGERY
Lo, E. H., FABRIKANT, J. I., Levy, R. P., Phillips, M. H., Frankel, K. A., & ALPEN, E. L. (1991). AN EXPERIMENTAL COMPARTMENTAL FLOW MODEL FOR ASSESSING THE HEMODYNAMIC-RESPONSE OF INTRACRANIAL ARTERIOVENOUS-MALFORMATIONS TO STEREOTAXIC RADIOSURGERY. NEUROSURGERY, 28(2), 251-259.

IDIOTYPE VACCINATION POST-BONE MARROW TRANSPLANTATION FOR B-CELL LYMPHOMA - INITIAL STUDIES IN A MURINE MODEL
Kwak, L. W., Campbell, M., & Levy, R. (1991). IDIOTYPE VACCINATION POST-BONE MARROW TRANSPLANTATION FOR B-CELL LYMPHOMA - INITIAL STUDIES IN A MURINE MODEL. CANCER DETECTION AND PREVENTION, 15(4), 323-325.

OBSERVATIONS ON THE EFFECT OF CHIMERIC ANTI-CD4 MONOCLONAL-ANTIBODY IN PATIENTS WITH MYCOSIS-FUNGOIDES
Knox, S. J., Levy, R., Hodgkinson, S., Bell, R., Brown, S., & Reichert, T. (1991). OBSERVATIONS ON THE EFFECT OF CHIMERIC ANTI-CD4 MONOCLONAL-ANTIBODY IN PATIENTS WITH MYCOSIS-FUNGOIDES. BLOOD, 77(1), 20-30.

HISTOLOGIC TRANSFORMATION OF FOLLICULAR LYMPHOMA TO DIFFUSE LYMPHOMA REPRESENTS TUMOR PROGRESSION BY A SINGLE MALIGNANT B-CELL
Zelenetz, A. D., Chen, T. T., & Levy, R. (1991). HISTOLOGIC TRANSFORMATION OF FOLLICULAR LYMPHOMA TO DIFFUSE LYMPHOMA REPRESENTS TUMOR PROGRESSION BY A SINGLE MALIGNANT B-CELL. JOURNAL OF EXPERIMENTAL MEDICINE, 173(1), 197-207.

COMBINED SYNGENEIC BONE-MARROW TRANSPLANTATION AND IMMUNOTHERAPY OF A MURINE B-CELL LYMPHOMA - ACTIVE IMMUNIZATION WITH TUMOR-DERIVED IDIOTYPIC IMMUNOGLOBULIN
Kwak, L. W., Campbell, M. J., Zelenetz, A. D., & Levy, R. (1990). COMBINED SYNGENEIC BONE-MARROW TRANSPLANTATION AND IMMUNOTHERAPY OF A MURINE B-CELL LYMPHOMA - ACTIVE IMMUNIZATION WITH TUMOR-DERIVED IDIOTYPIC IMMUNOGLOBULIN. BLOOD, 76(11), 2411-2417.

TAPA-1, THE TARGET OF AN ANTIPROLIFERATIVE ANTIBODY, IS ASSOCIATED ON THE CELL-SURFACE WITH THE LEU-13 ANTIGEN
Takahashi, S., Doss, C., Levy, S., & Levy, R. (1990). TAPA-1, THE TARGET OF AN ANTIPROLIFERATIVE ANTIBODY, IS ASSOCIATED ON THE CELL-SURFACE WITH THE LEU-13 ANTIGEN. JOURNAL OF IMMUNOLOGY, 145(7), 2207-2213.

DETERMINANTS OF THE ANTITUMOR EFFECT OF RADIOLABELED MONOCLONAL-ANTIBODIES
Knox, S. J., Levy, R., MILLER, R. A., UHLAND, W., Schiele, J., & Goris, M. L. (1990). DETERMINANTS OF THE ANTITUMOR EFFECT OF RADIOLABELED MONOCLONAL-ANTIBODIES. CANCER RESEARCH, 50(16), 4935-4940.

TAPA-1, THE TARGET OF AN ANTIPROLIFERATIVE ANTIBODY, DEFINES A NEW FAMILY OF TRANSMEMBRANE PROTEINS
Oren, R., Takahashi, S., Doss, C., Levy, R., & Levy, S. (1990). TAPA-1, THE TARGET OF AN ANTIPROLIFERATIVE ANTIBODY, DEFINES A NEW FAMILY OF TRANSMEMBRANE PROTEINS. MOLECULAR AND CELLULAR BIOLOGY, 10(8), 4007-4015.

IDIOTYPE VACCINATION AGAINST MURINE B-CELL LYMPHOMA - HUMORAL AND CELLULAR-REQUIREMENTS FOR THE FULL EXPRESSION OF ANTITUMOR IMMUNITY
Campbell, M. J., Esserman, L., BYARS, N. E., Allison, A. C., & Levy, R. (1990). IDIOTYPE VACCINATION AGAINST MURINE B-CELL LYMPHOMA - HUMORAL AND CELLULAR-REQUIREMENTS FOR THE FULL EXPRESSION OF ANTITUMOR IMMUNITY. JOURNAL OF IMMUNOLOGY, 145(3), 1029-1036.

STEREOTAXIC HEAVY-CHARGED-PARTICLE BRAGG-PEAK RADIATION FOR INTRACRANIAL ARTERIOVENOUS-MALFORMATIONS
Steinberg, G. K., FABRIKANT, J. I., Marks, M. P., Levy, R. P., Frankel, K. A., & Silverberg, G. D. (1990). STEREOTAXIC HEAVY-CHARGED-PARTICLE BRAGG-PEAK RADIATION FOR INTRACRANIAL ARTERIOVENOUS-MALFORMATIONS. NEW ENGLAND JOURNAL OF MEDICINE, 323(2), 96-101.

DIRECTIONAL CLONING OF CDNA USING A SELECTABLE SFII CASSETTE
Zelenetz, A. D., & Levy, R. (1990). DIRECTIONAL CLONING OF CDNA USING A SELECTABLE SFII CASSETTE. GENE, 89(1), 123-127.

INDUCTION OF PROLIFERATION OF HUMAN FOLLICULAR (B-TYPE) LYMPHOMA-CELLS BY COGNATE INTERACTION WITH CD4+ T-CELL CLONES
Umetsu, D. T., Esserman, L., Donlon, T. A., DeKruyff, R. H., & Levy, R. (1990). INDUCTION OF PROLIFERATION OF HUMAN FOLLICULAR (B-TYPE) LYMPHOMA-CELLS BY COGNATE INTERACTION WITH CD4+ T-CELL CLONES. JOURNAL OF IMMUNOLOGY, 144(7), 2550-2557.

IDIOTYPIC VARIATION IN A HUMAN B-LYMPHOMA CELL-LINE
Berinstein, N., Campbell, M. J., Lam, K., CARSWELL, C., Levy, S., & Levy, R. (1990). IDIOTYPIC VARIATION IN A HUMAN B-LYMPHOMA CELL-LINE. JOURNAL OF IMMUNOLOGY, 144(2), 752-758.

Therapy of lymphoma directed at idiotypes.
Levy, R., & MILLER, R. A. (1990). Therapy of lymphoma directed at idiotypes. Journal of the National Cancer Institute. Monographs, (10), 61-68.

AN EPITOPE OF THE TRANSFERRIN RECEPTOR IS EXPOSED ON THE CELL-SURFACE OF HIGH-GRADE BUT NOT LOW-GRADE HUMAN LYMPHOMAS
Esserman, L., Takahashi, S., Rojas, V., Warnke, R., & Levy, R. (1989). AN EPITOPE OF THE TRANSFERRIN RECEPTOR IS EXPOSED ON THE CELL-SURFACE OF HIGH-GRADE BUT NOT LOW-GRADE HUMAN LYMPHOMAS. BLOOD, 74(8), 2718-2729.

DNA FRAGMENTATION AND CELL-DEATH MEDIATED BY T-CELL ANTIGEN RECEPTOR CD3 COMPLEX ON A LEUKEMIA T-CELL LINE
Takahashi, S., Maecker, H. T., & Levy, R. (1989). DNA FRAGMENTATION AND CELL-DEATH MEDIATED BY T-CELL ANTIGEN RECEPTOR CD3 COMPLEX ON A LEUKEMIA T-CELL LINE. EUROPEAN JOURNAL OF IMMUNOLOGY, 19(10), 1911-1919.

FUNCTIONAL IMMUNOGLOBULIN LIGHT CHAIN GENES ARE REPLACED BY ONGOING REARRANGEMENTS OF GERMLINE VK GENES TO DOWNSTREAM JK SEGMENTS IN A MURINE B-CELL LINE
Levy, S., Campbell, M. J., & Levy, R. (1989). FUNCTIONAL IMMUNOGLOBULIN LIGHT CHAIN GENES ARE REPLACED BY ONGOING REARRANGEMENTS OF GERMLINE VK GENES TO DOWNSTREAM JK SEGMENTS IN A MURINE B-CELL LINE. JOURNAL OF EXPERIMENTAL MEDICINE, 170(1), 1-13.

ANTIIDIOTYPE ANTIBODY THERAPY OF B-CELL LYMPHOMA
Brown, S. L., MILLER, R. A., & Levy, R. (1989). ANTIIDIOTYPE ANTIBODY THERAPY OF B-CELL LYMPHOMA. SEMINARS IN ONCOLOGY, 16(3), 199-210.

CYTO-TOXIC LYMPHOCYTE-T SPECIFIC FOR SELF TUMOR IMMUNOGLOBULIN EXPRESS T-CELL RECEPTOR DELTA-CHAIN
Wright, A., Lee, J. E., Link, M. P., Smith, S. D., Carroll, W., & KRENSKY, A. M. (1989). CYTO-TOXIC LYMPHOCYTE-T SPECIFIC FOR SELF TUMOR IMMUNOGLOBULIN EXPRESS T-CELL RECEPTOR DELTA-CHAIN. JOURNAL OF EXPERIMENTAL MEDICINE, 169(5), 1557-1564.

ACTIVATION OF AN EXCLUDED IMMUNOGLOBULIN ALLELE IN A HUMAN B-LYMPHOMA CELL-LINE
Berinstein, N., Levy, S., & Levy, R. (1989). ACTIVATION OF AN EXCLUDED IMMUNOGLOBULIN ALLELE IN A HUMAN B-LYMPHOMA CELL-LINE. SCIENCE, 244(4902), 337-339.

TREATMENT OF B-CELL LYMPHOMAS WITH ANTI-IDIOTYPE ANTIBODIES ALONE AND IN COMBINATION WITH ALPHA INTERFERON
Brown, S. L., MILLER, R. A., Horning, S. J., Czerwinski, D., Hart, S. M., & Levy, R. (1989). TREATMENT OF B-CELL LYMPHOMAS WITH ANTI-IDIOTYPE ANTIBODIES ALONE AND IN COMBINATION WITH ALPHA INTERFERON. BLOOD, 73(3), 651-661.

PREVALENCE OF ANTIGEN RECEPTOR VARIANTS IN HUMAN T-CELL LINES AND TUMORS
Maecker, H. T., & Levy, R. (1989). PREVALENCE OF ANTIGEN RECEPTOR VARIANTS IN HUMAN T-CELL LINES AND TUMORS. JOURNAL OF IMMUNOLOGY, 142(4), 1395-1404.

Development of a new therapeutic approach to B cell malignancy. The induction of immunity by the host against cell surface receptor on the tumor.
Campbell, M. J., Esserman, L., BYARS, N. E., Allison, A. C., & Levy, R. (1989). Development of a new therapeutic approach to B cell malignancy. The induction of immunity by the host against cell surface receptor on the tumor. International reviews of immunology, 4(4), 251-270.

IMMUNOTHERAPY OF ESTABLISHED MURINE B-CELL LYMPHOMA - COMBINATION OF IDIOTYPE IMMUNIZATION AND CYCLOPHOSPHAMIDE
Campbell, M. J., Esserman, L., & Levy, R. (1988). IMMUNOTHERAPY OF ESTABLISHED MURINE B-CELL LYMPHOMA - COMBINATION OF IDIOTYPE IMMUNIZATION AND CYCLOPHOSPHAMIDE. JOURNAL OF IMMUNOLOGY, 141(9), 3227-3233.

ALTERNATIVE V-KAPPA GENE REARRANGEMENTS IN A MURINE B-CELL LYMPHOMA - AN EXPLANATION FOR IDIOTYPIC HETEROGENEITY
Carroll, W. L., Starnes, C. O., Levy, R., & Levy, S. (1988). ALTERNATIVE V-KAPPA GENE REARRANGEMENTS IN A MURINE B-CELL LYMPHOMA - AN EXPLANATION FOR IDIOTYPIC HETEROGENEITY. JOURNAL OF EXPERIMENTAL MEDICINE, 168(5), 1607-1620.

SPONTANEOUS T-CELL ANTIGEN RECEPTOR VARIANTS OF A HUMAN T-LEUKEMIA CELL-LINE
Maecker, H. T., & Levy, R. (1988). SPONTANEOUS T-CELL ANTIGEN RECEPTOR VARIANTS OF A HUMAN T-LEUKEMIA CELL-LINE. JOURNAL OF IMMUNOLOGY, 141(9), 2994-3002.

SYNERGISTIC ANTITUMOR-ACTIVITY WITH IFN AND MONOCLONAL ANTI-IDIOTYPE FOR MURINE B-CELL LYMPHOMA - MECHANISM OF ACTION
BASHAM, T. Y., RACE, E. R., Campbell, M. J., Reid, T. R., Levy, R., & Merigan, T. C. (1988). SYNERGISTIC ANTITUMOR-ACTIVITY WITH IFN AND MONOCLONAL ANTI-IDIOTYPE FOR MURINE B-CELL LYMPHOMA - MECHANISM OF ACTION. JOURNAL OF IMMUNOLOGY, 141(8), 2855-2860.

MUTATIONAL HOT SPOTS IN IG V-REGION GENES OF HUMAN FOLLICULAR LYMPHOMAS
Levy, S., Mendel, E., Kon, S., Avnur, Z., & Levy, R. (1988). MUTATIONAL HOT SPOTS IN IG V-REGION GENES OF HUMAN FOLLICULAR LYMPHOMAS. JOURNAL OF EXPERIMENTAL MEDICINE, 168(2), 475-489.

COMPARISON OF COMBINATIONS OF INTERFERONS WITH TUMOR SPECIFIC AND NONSPECIFIC MONOCLONAL-ANTIBODIES AS THERAPY FOR MURINE B-CELL AND T-CELL LYMPHOMAS
BASHAM, T. Y., Palladino, M. A., BADGER, C. C., Bernstein, I. D., Levy, R., & Merigan, T. C. (1988). COMPARISON OF COMBINATIONS OF INTERFERONS WITH TUMOR SPECIFIC AND NONSPECIFIC MONOCLONAL-ANTIBODIES AS THERAPY FOR MURINE B-CELL AND T-CELL LYMPHOMAS. CANCER RESEARCH, 48(15), 4196-4200.

HETEROGENEITY OF A MURINE B-CELL LYMPHOMA - ISOLATION AND CHARACTERIZATION OF IDIOTYPIC VARIANTS
Starnes, C. O., Carroll, W. L., Campbell, M. J., Houston, L. L., Apell, G., & Levy, R. (1988). HETEROGENEITY OF A MURINE B-CELL LYMPHOMA - ISOLATION AND CHARACTERIZATION OF IDIOTYPIC VARIANTS. JOURNAL OF IMMUNOLOGY, 141(1), 333-339.

SPECIFIC ENHANCEMENT OF THE THERAPEUTIC EFFECT OF ANTI-IDIOTYPE ANTIBODIES ON A MURINE B-CELL LYMPHOMA BY IL-2
Berinstein, N., Starnes, C. O., & Levy, R. (1988). SPECIFIC ENHANCEMENT OF THE THERAPEUTIC EFFECT OF ANTI-IDIOTYPE ANTIBODIES ON A MURINE B-CELL LYMPHOMA BY IL-2. JOURNAL OF IMMUNOLOGY, 140(8), 2839-2845.

IDIOTYPE AS A TUMOR-SPECIFIC MARKER IN CHILDHOOD B-CELL ACUTE LYMPHOBLASTIC-LEUKEMIA
Carroll, W. L., Link, M. P., Cleary, M. L., Bologna, S., CARSWELL, C., & Levy, R. (1988). IDIOTYPE AS A TUMOR-SPECIFIC MARKER IN CHILDHOOD B-CELL ACUTE LYMPHOBLASTIC-LEUKEMIA. BLOOD, 71(4), 1068-1073.

SINGLE CELL ORIGIN OF BIGENOTYPIC AND BIPHENOTYPIC B-CELL PROLIFERATIONS IN HUMAN FOLLICULAR LYMPHOMAS
Cleary, M. L., Galili, N., Trela, M., Levy, R., & Sklar, J. (1988). SINGLE CELL ORIGIN OF BIGENOTYPIC AND BIPHENOTYPIC B-CELL PROLIFERATIONS IN HUMAN FOLLICULAR LYMPHOMAS. JOURNAL OF EXPERIMENTAL MEDICINE, 167(2), 582-597.

ANTIBODY-DIRECTED TARGETING OF LIPOSOMES TO HUMAN CELL-LINES - ROLE OF BINDING AND INTERNALIZATION ON GROWTH-INHIBITION
Berinstein, N., Matthay, K. K., Papahadjopoulos, D., Levy, R., & Sikic, B. I. (1987). ANTIBODY-DIRECTED TARGETING OF LIPOSOMES TO HUMAN CELL-LINES - ROLE OF BINDING AND INTERNALIZATION ON GROWTH-INHIBITION. CANCER RESEARCH, 47(22), 5954-5959.

IDIOTYPE VACCINATION AGAINST MURINE B-CELL LYMPHOMA - HUMORAL AND CELLULAR-RESPONSES ELICITED BY TUMOR-DERIVED IMMUNOGLOBULIN-M AND ITS MOLECULAR SUBUNITS
Campbell, M. J., Carroll, W., Kon, S., Thielemans, K., Rothbard, J. B., & Levy, R. (1987). IDIOTYPE VACCINATION AGAINST MURINE B-CELL LYMPHOMA - HUMORAL AND CELLULAR-RESPONSES ELICITED BY TUMOR-DERIVED IMMUNOGLOBULIN-M AND ITS MOLECULAR SUBUNITS. JOURNAL OF IMMUNOLOGY, 139(8), 2825-2833.

TREATMENT OF A MURINE B-CELL LYMPHOMA WITH MONOCLONAL-ANTIBODIES AND IL-2
Berinstein, N., & Levy, R. (1987). TREATMENT OF A MURINE B-CELL LYMPHOMA WITH MONOCLONAL-ANTIBODIES AND IL-2. JOURNAL OF IMMUNOLOGY, 139(3), 971-976.

ISOLATION OF ANTIIDIOTYPIC ANTIBODIES TO T-CELLS USING AN ANTI-FRAMEWORK DETERMINANT ANTIBODY
Maecker, H. T., Kitamura, K., Brenner, M. B., & Levy, R. (1987). ISOLATION OF ANTIIDIOTYPIC ANTIBODIES TO T-CELLS USING AN ANTI-FRAMEWORK DETERMINANT ANTIBODY. JOURNAL OF IMMUNOLOGICAL METHODS, 98(2), 219-226.

INVITRO TESTS THAT PREDICT TUMOR-ASSOCIATED IDIOTYPE LEVELS IN THE SERUM OF PATIENTS WITH B-CELL LYMPHOMAS AND LEUKEMIAS
MILLER, R. A., Lowder, J. N., Gralow, J., Meeker, T., & Levy, R. (1987). INVITRO TESTS THAT PREDICT TUMOR-ASSOCIATED IDIOTYPE LEVELS IN THE SERUM OF PATIENTS WITH B-CELL LYMPHOMAS AND LEUKEMIAS. BLOOD, 69(4), 1249-1254.

STUDIES ON B-LYMPHOID TUMORS TREATED WITH MONOCLONAL ANTIIDIOTYPE ANTIBODIES - CORRELATION WITH CLINICAL-RESPONSES
Lowder, J. N., MEEKER, T. C., Campbell, M., Garcia, C. F., Gralow, J., & Levy, R. (1987). STUDIES ON B-LYMPHOID TUMORS TREATED WITH MONOCLONAL ANTIIDIOTYPE ANTIBODIES - CORRELATION WITH CLINICAL-RESPONSES. BLOOD, 69(1), 199-210.

ANTI-IDIOTYPE ANTIBODIES REVEAL THE EXISTENCE OF SOMATIC MUTATION IN HUMAN B-CELL LYMPHOMA
Levy, R., Levy, S., Brown, S. L., Kon, S., & Carroll, W. (1987). ANTI-IDIOTYPE ANTIBODIES REVEAL THE EXISTENCE OF SOMATIC MUTATION IN HUMAN B-CELL LYMPHOMA. MONOGRAPHS IN ALLERGY, 22, 194-203.

SYNERGISTIC ANTITUMOR EFFECT OF INTERFERON AND ANTIIDIOTYPE MONOCLONAL-ANTIBODY IN MURINE LYMPHOMA
BASHAM, T. Y., Kaminski, M. S., Kitamura, K., Levy, R., & Merigan, T. C. (1986). SYNERGISTIC ANTITUMOR EFFECT OF INTERFERON AND ANTIIDIOTYPE MONOCLONAL-ANTIBODY IN MURINE LYMPHOMA. JOURNAL OF IMMUNOLOGY, 137(9), 3019-3024.

A UNIQUE ANTIGEN ON MATURE B-CELLS DEFINED BY A MONOCLONAL-ANTIBODY
Link, M. P., Bindl, J., MEEKER, T. C., CARSWELL, C., DOSS, C. A., & Levy, R. (1986). A UNIQUE ANTIGEN ON MATURE B-CELLS DEFINED BY A MONOCLONAL-ANTIBODY. JOURNAL OF IMMUNOLOGY, 137(9), 3013-3018.

MOUSE X HUMAN HETEROHYBRIDOMAS AS FUSION PARTNERS WITH HUMAN B-CELL TUMORS
Carroll, W. L., Thielemans, K., Dilley, J., & Levy, R. (1986). MOUSE X HUMAN HETEROHYBRIDOMAS AS FUSION PARTNERS WITH HUMAN B-CELL TUMORS. JOURNAL OF IMMUNOLOGICAL METHODS, 89(1), 61-72.

CLUSTERING OF EXTENSIVE SOMATIC MUTATIONS IN THE VARIABLE REGION OF AN IMMUNOGLOBULIN HEAVY-CHAIN GENE FROM A HUMAN B-CELL LYMPHOMA
Cleary, M. L., MEEKER, T. C., Levy, S., Lee, E., Trela, M., & Levy, R. (1986). CLUSTERING OF EXTENSIVE SOMATIC MUTATIONS IN THE VARIABLE REGION OF AN IMMUNOGLOBULIN HEAVY-CHAIN GENE FROM A HUMAN B-CELL LYMPHOMA. CELL, 44(1), 97-106.

The immunobiology of B cell lymphoma: clonal heterogeneity as revealed by anti-idiotype antibodies and immunoglobulin gene probes.
Levy, R., Meeker, T., Lowder, J., Levy, S., Thielemans, K., & Sklar, J. (1986). The immunobiology of B cell lymphoma: clonal heterogeneity as revealed by anti-idiotype antibodies and immunoglobulin gene probes. Symposium on Fundamental Cancer Research, 38, 261-268.

DETECTION OF B-CELL LYMPHOMA IN PERIPHERAL-BLOOD BY DNA HYBRIDIZATION
Hu, E., Thompson, J., Horning, S., Trela, M., Lowder, J., & Sklar, J. (1985). DETECTION OF B-CELL LYMPHOMA IN PERIPHERAL-BLOOD BY DNA HYBRIDIZATION. LANCET, 2(8464), 1092-1095.

SYNGENEIC ANTIIDIOTYPIC IMMUNE-RESPONSES TO A B-CELL LYMPHOMA - COMPARISON BETWEEN HEAVY-CHAIN HYPERVARIABLE REGION PEPTIDES AND INTACT IG AS IMMUNOGENS
Thielemans, K., Rothbard, J. B., Levy, S., & Levy, R. (1985). SYNGENEIC ANTIIDIOTYPIC IMMUNE-RESPONSES TO A B-CELL LYMPHOMA - COMPARISON BETWEEN HEAVY-CHAIN HYPERVARIABLE REGION PEPTIDES AND INTACT IG AS IMMUNOGENS. JOURNAL OF EXPERIMENTAL MEDICINE, 162(1), 19-34.

MONOCLONAL-ANTIBODY THERAPY OF LYMPHOID MALIGNANCY
Lowder, J. N., MEEKER, T. C., & Levy, R. (1985). MONOCLONAL-ANTIBODY THERAPY OF LYMPHOID MALIGNANCY. CANCER SURVEYS, 4(2), 359-375.

EMERGENCE OF IDIOTYPE VARIANTS DURING TREATMENT OF B-CELL LYMPHOMA WITH ANTI-IDIOTYPE ANTIBODIES
Meeker, T., Lowder, J., Cleary, M. L., Stewart, S., Warnke, R., & Levy, R. (1985). EMERGENCE OF IDIOTYPE VARIANTS DURING TREATMENT OF B-CELL LYMPHOMA WITH ANTI-IDIOTYPE ANTIBODIES. NEW ENGLAND JOURNAL OF MEDICINE, 312(26), 1658-1665.

A CLINICAL-TRIAL OF ANTI-IDIOTYPE THERAPY FOR B-CELL MALIGNANCY
MEEKER, T. C., Lowder, J., Maloney, D. G., MILLER, R. A., Thielemans, K., & Levy, R. (1985). A CLINICAL-TRIAL OF ANTI-IDIOTYPE THERAPY FOR B-CELL MALIGNANCY. BLOOD, 65(6), 1349-1363.

DIFFERENCES IN HOST INFILTRATES AMONG LYMPHOMA PATIENTS TREATED WITH ANTI-IDIOTYPE ANTIBODIES - CORRELATION WITH TREATMENT RESPONSE
Garcia, C. F., Lowder, J., MEEKER, T. C., Bindl, J., Levy, R., & Warnke, R. A. (1985). DIFFERENCES IN HOST INFILTRATES AMONG LYMPHOMA PATIENTS TREATED WITH ANTI-IDIOTYPE ANTIBODIES - CORRELATION WITH TREATMENT RESPONSE. JOURNAL OF IMMUNOLOGY, 135(6), 4252-4260.

STRATEGIES FOR PRODUCTION OF MONOCLONAL ANTI-IDIOTYPE ANTIBODIES AGAINST HUMAN B-CELL LYMPHOMAS
Thielemans, K., Maloney, D. G., Meeker, T., Fujimoto, J., Doss, C., & Levy, R. (1984). STRATEGIES FOR PRODUCTION OF MONOCLONAL ANTI-IDIOTYPE ANTIBODIES AGAINST HUMAN B-CELL LYMPHOMAS. JOURNAL OF IMMUNOLOGY, 133(1), 495-501.

BICLONAL B-CELL LYMPHOMA
Sklar, J., Cleary, M. L., Thielemans, K., Gralow, J., Warnke, R., & Levy, R. (1984). BICLONAL B-CELL LYMPHOMA. NEW ENGLAND JOURNAL OF MEDICINE, 311(1), 20-27.

CLINICAL RELEVANCE OF IMMUNOLOGICAL PHENOTYPE IN DIFFUSE LARGE CELL LYMPHOMA
Horning, S. J., Doggett, R. S., Warnke, R. A., Dorfman, R. F., Cox, R. S., & Levy, R. (1984). CLINICAL RELEVANCE OF IMMUNOLOGICAL PHENOTYPE IN DIFFUSE LARGE CELL LYMPHOMA. BLOOD, 63(5), 1209-1215.

PAN-LEUKOCYTE MONOCLONAL ANTIBODY-L3B12 - CHARACTERIZATION AND APPLICATION TO RESEARCH AND DIAGNOSTIC PROBLEMS
Wood, G. S., Link, M., Warnke, R. A., Dilley, J., & Levy, R. (1984). PAN-LEUKOCYTE MONOCLONAL ANTIBODY-L3B12 - CHARACTERIZATION AND APPLICATION TO RESEARCH AND DIAGNOSTIC PROBLEMS. AMERICAN JOURNAL OF CLINICAL PATHOLOGY, 81(2), 176-183.

THE IMMUNOLOGICAL CHARACTERIZATION OF 95 NODAL AND EXTRANODAL DIFFUSE LARGE CELL LYMPHOMAS IN 89 PATIENTS
Doggett, R. S., Wood, G. S., Horning, S., Levy, R., Dorfman, R. F., & Warnke, R. A. (1984). THE IMMUNOLOGICAL CHARACTERIZATION OF 95 NODAL AND EXTRANODAL DIFFUSE LARGE CELL LYMPHOMAS IN 89 PATIENTS. AMERICAN JOURNAL OF PATHOLOGY, 115(2), 245-252.

A UNIQUE HUMAN LYMPHOCYTE-B ANTIGEN DEFINED BY A MONOCLONAL-ANTIBODY
MEEKER, T. C., MILLER, R. A., Link, M. P., Bindl, J., Warnke, R., & Levy, R. (1984). A UNIQUE HUMAN LYMPHOCYTE-B ANTIGEN DEFINED BY A MONOCLONAL-ANTIBODY. HYBRIDOMA, 3(4), 305-320.

A SINGLE MONOCLONAL-ANTIBODY IDENTIFIES T-CELL LINEAGE OF CHILDHOOD LYMPHOID MALIGNANCIES
Link, M., Warnke, R., Finlay, J., Amylon, M., Miller, R., & Levy, R. (1983). A SINGLE MONOCLONAL-ANTIBODY IDENTIFIES T-CELL LINEAGE OF CHILDHOOD LYMPHOID MALIGNANCIES. BLOOD, 62(4), 722-728.

STANFORD STUDY OF SEZARY SYNDROME
Rich, L., Levy, R., Horning, S., & Merigan, T. C. (1983). STANFORD STUDY OF SEZARY SYNDROME. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 9(2), 279-279.

STUDIES OF A HUMAN LYMPHOCYTE-T ANTIGEN RECOGNIZED BY A MONOCLONAL-ANTIBODY
Engleman, E. G., Warnke, R., FOX, R. I., Dilley, J., Benike, C. J., & Levy, R. (1981). STUDIES OF A HUMAN LYMPHOCYTE-T ANTIGEN RECOGNIZED BY A MONOCLONAL-ANTIBODY. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA-BIOLOGICAL SCIENCES, 78(3), 1791-1795.

INHIBITION OF LYMPHOMA HYBRIDS BY HUMAN INTERFERON
Sikora, K., Dilley, J., Merigan, T., BASHAM, T., & Levy, R. (1980). INHIBITION OF LYMPHOMA HYBRIDS BY HUMAN INTERFERON. LANCET, 2(8200), 891-893.

HUMAN THYMUS-LEUKEMIA ANTIGEN DEFINED BY HYBRIDOMA MONOCLONAL-ANTIBODIES
Levy, R., Dilley, J., FOX, R. I., & Warnke, R. (1979). HUMAN THYMUS-LEUKEMIA ANTIGEN DEFINED BY HYBRIDOMA MONOCLONAL-ANTIBODIES. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 76(12), 6552-6556.

PRELIMINARY-OBSERVATIONS ON EFFECT OF HUMAN LEUKOCYTE INTERFERON IN NON-HODGKINS LYMPHOMA
Merigan, T. C., Sikora, K., BREEDEN, J. H., Levy, R., & Rosenberg, S. A. (1978). PRELIMINARY-OBSERVATIONS ON EFFECT OF HUMAN LEUKOCYTE INTERFERON IN NON-HODGKINS LYMPHOMA. NEW ENGLAND JOURNAL OF MEDICINE, 299(26), 1449-1453.